Navigation Links
ASTMH Symposium Showcases Efforts To Meet the Need for New Medicines to Treat Infectious Diseases in Developing Countries
Date:11/21/2009

WASHINGTON, Nov. 21 /PRNewswire/ -- An urgent need for new medicines to treat neglected infectious diseases in the developing world has prompted a growing number of collaborations among academic researchers, non-profit product development partnerships (PDPs), and pharmaceutical and biotechnology companies. As noted today in a symposium at the 58th annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH), these collaborations are opening up new avenues of access to industry technology, expertise, and capabilities, enabling the harnessing of industry resources for new product innovation.

The need for these collaborations between industry and global health non-profits results from the lack of effective prevention or treatments for many infectious diseases of the developing world. There is a tremendous need for new R&D that could lead to new cures. Despite substantial progress in improving delivery of existing medicines for infectious diseases in the developing world, there are still major gaps in disease prevention, diagnosis, and treatment that must be alleviated through development of new medicines.

"Industry/public sector product development collaborations are one of the success stories for the developing world, as biopharmaceutical companies are discovering that investment in global health R&D is consistent with their broader commercial strategies," observed Dr. Christopher D. Earl, former chief executive officer of BIO Ventures for Global Health, who organized the symposium. "The participants in this symposium highlight how their organizations have made substantial progress in moving unused compounds from companies' shelves to the laboratory and ultimately to the clinic. By allowing experts access to assets that industry has amassed, these collaborations have spurred the development of new medicines for malaria, tuberculosis, and various parasite-borne diseases."

The symposium, "Rummag
'/>"/>

SOURCE The American Society of Tropical Medicine and Hygiene
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 17, 2009
2. US Oncology, Inc. to Exhibit iKnowMed(TM) at the 2009 ASCO EHR Symposium: Harnessing the EHR: From Incentives to Sustainability
3. Keryx Biopharmaceuticals Phase 2 Data of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Renal Cell Cancer Selected for Oral Presentation at the Eighth International Kidney Cancer Symposium
4. DaVita Abstracts Accepted Into National Kidney Foundations 2009 Spring Symposium
5. Anti-Aging Expo & Symposium Showcases in Charlotte on March 28th
6. Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections
7. Hope for 14 Million Rosacea Sufferers: Pyratine-XR(TM) Study to be Presented at South Beach Symposium
8. Three Clinical Studies of bioTheranostics Molecular Breast Cancer Diagnostics Presented at San Antonio Breast Cancer Symposium
9. Agendia Supports High Profile CME Symposium and Presents Compelling Data at the 2008 San Antonio Breast Cancer Symposium
10. Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium
11. Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) announces the ... StockholdersWhen:Tuesday, June 30 at 5:10 p.m. ET / 2:10 ... onto our website listed above.   If ... a replay of the webcast will be available for ... ABOUT ISIS PHARMACEUTICALS, INC. Isis is exploiting ...
(Date:6/29/2015)... 30, 2015 , Gerresheimer will sell ... and Gerresheimer enter into a 10-year-supply agreement for pharmaceutical ... EUR 196m debt-free Corning and Gerresheimer will ... glass packaging market Gerresheimer,s outlook for the financial ... disposal of the tubing business , In line ...
(Date:6/29/2015)... 29, 2015  Nevro Corp. (NYSE: NVRO ), ... evidence-based solutions for the treatment of chronic pain, today ... Executive Officer of Intersect ENT (NASDAQ: XENT ), ... June 28, 2015. For the last ... Intersect ENT, a company dedicated to improving the quality ...
Breaking Medicine Technology:Webcast Alert: Corporate Presentation at the 2015 Isis Pharmaceuticals Annual Stockholder Meeting 2Webcast Alert: Corporate Presentation at the 2015 Isis Pharmaceuticals Annual Stockholder Meeting 3Gerresheimer Will Sell Tubing Operations to Corning - Both Will Form a Joint Venture to Accelerate Innovations for Pharmaceutical Glass Packaging Market 2Gerresheimer Will Sell Tubing Operations to Corning - Both Will Form a Joint Venture to Accelerate Innovations for Pharmaceutical Glass Packaging Market 3Nevro Appoints Lisa Earnhardt to its Board of Directors 2
... HAIFA, Israel, November 11 Cardio Vascular,Medical ... advanced,cardiovascular surgery technology, today announced the completion of ... . , Cardio Vascular ... innovative,next-generation "steerable guidewire" applicable for all angioplasty (PCTA),procedures. ...
... ACCESS PHARMACEUTICALS, INC. (OTC Bulletin ... commercial launch of MuGard, an FDA approved treatment for oral ... Access intends to commercially launch MuGard in North America ... pertaining to the launch include: , Manufacturing : ...
Cached Medicine Technology:Cardio Vascular Medical Device Launches Corporate Website 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America 4
(Date:6/30/2015)... ... June 30, 2015 , ... The Citizens Commission ... Davis (D-IL) for writing to the Department of Health and Human Services (HHS), ... healthcare system, Universal Health Services (UHS).[1] CCHR is expanding its seven-year review of ...
(Date:6/30/2015)... ... June 30, 2015 , ... Nuretix Research, creators of ... Zone Miami (KO Zone), a state-of-the-art training facility owned by leading ... de Vera. The partnership will provide KO Zone clients and athletes with Liporidex ...
(Date:6/30/2015)... ... June 30, 2015 , ... Under ... protection at less thickness than any other padding in football. , Developed in ... and shock absorption, Gameday Armour is engineered with D3O protective polymer. This radical ...
(Date:6/30/2015)... ... June 30, 2015 , ... Experts estimate that up to ... Back pain can range from a dull, constant ache (chronic) to a sudden sharp ... epidural steroid injections, selective nerve root blocks and rhizotomy treatment, OPTIMAL Pain & ...
(Date:6/30/2015)... ... 30, 2015 , ... People who want to learn more ... a near-death experience (NDE) – and also want to understand why the military ... – are invited to visit https://zoom.us/webinar/register/f4a12556fe7c03f5dc2040ba88984b7b and RSVP their attendance at ...
Breaking Medicine News(10 mins):Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 2Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 3Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 4Health News:CCHR Seeks Public Input on Psychotropic Drug Billing and Psychiatric Abuse: Applauds Congressmen for Behavioral Hospitals Investigation Call 5Health News:Top Sports Nutrition Brand, Liporidex, Announces Partnership With Leading Boxing, CrossFit and MMA Gym, Knockout Zone of Miami 2Health News:Top Sports Nutrition Brand, Liporidex, Announces Partnership With Leading Boxing, CrossFit and MMA Gym, Knockout Zone of Miami 3Health News:Under Armour Launches Advanced Gameday Armour® Max Protection System For The Gridiron 2Health News:OPTIMAL Pain & Regenerative Medicine Brings Innovative Back Pain Management Options Including PRP Injections and Stem Cell-like Therapies to Dallas/Ft. Worth Metroplex 2Health News:OPTIMAL Pain & Regenerative Medicine Brings Innovative Back Pain Management Options Including PRP Injections and Stem Cell-like Therapies to Dallas/Ft. Worth Metroplex 3Health News:IANDS Sponsors No-Cost Webinar on July 1/15 at 11CST Featuring Combat Soldier Who Survived Near-Death Experience 2Health News:IANDS Sponsors No-Cost Webinar on July 1/15 at 11CST Featuring Combat Soldier Who Survived Near-Death Experience 3
... Assia, of Tel Aviv Universitys Sackler School of Medicine is, ... surgery. , One of a small number of surgeons in ... surgery, Prof. Assia has developed a novel laser device that ... the OTS134 for now, is expected to give most practicing ...
... Sept. 14, 2007 -- A new study by researchers at ... be good for you. , Researchers found that a ... with teen obesity, hypertension and healthy eating habits had a ... among men. , The study, published in the Sept. 14 ...
... department reported that their anxiety levels fell dramatically when they ... research in the September issue of the UK-based Journal of ... provided over the course of a year. 86 nurses participated ... summer and winter sessions. , Researchers found that 60 ...
... kill off cancer cells, experts say , FRIDAY, Sept. ... called unplanned cell death, or necrosis, could help in ... life-threatening conditions, scientists say. , Necrosis is not the ... Necrosis is an unplanned cell death caused by outside ...
... offers possible advance over invasive tests , , FRIDAY, Sept. ... a mother-to-be,s blood could become the lens through which ... a new study suggests. , "It,s amazing that all ... in their blood," said Dr. Jill L. Maron, the ...
... N.J., Sept. 21 Schering-Plough,Corporation (NYSE: SGP ) ... the 2007 third quarter on Monday, Oct. 22, 2007. ... will conduct a conference,call to review results for the ... other members of management will,host the conference call. ...
Cached Medicine News:Health News:Glaucoma surgery in the blink of an eye 2Health News:ER episode impacts viewers' health knowledge and behavior 2Health News:Giving emergency nurses aromatherapy massages with music dramatically reduced stress levels 2Health News:Giving emergency nurses aromatherapy massages with music dramatically reduced stress levels 3Health News:Clues to Cell Death Could Fight Disease 2Health News:Mother's Blood Could Offer Insights Into Fetal Health 2Health News:Mother's Blood Could Offer Insights Into Fetal Health 3
Shandon Microscope Slide Cabinet with Drawers...
... data from multiple sources is not ... ResultNet/Plus software allows you to concentrate ... communications network., ,ResultNet/Plus eliminates the complexity ... largescale or multi-site laboratories to host ...
The flexible EXXCEL ePTFE Vascular Access Graft material is designed to offer textile-like handling characteristics-cuts neatly for a clean edge, retains fully open lumen shape, and sutures smoothly....
ACE Control Serum provides the laboratory with vital information on the performance of the ACE chemistry assay....
Medicine Products: